Engineering the immune system to overcome tumor evasion strategies was a hot topic at this week’s AACR meeting, with researchers discussing several new approaches.
By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.